Works by Chakradhara Rao, Uppugunduri S.

Results: 15
    1

    The Association of Combined GSTM1 and CYP2C9 Genotype Status with the Occurrence of Hemorrhagic Cystitis in Pediatric Patients Receiving Myeloablative Conditioning Regimen Prior to Allogeneic Hematopoietic Stem Cell Transplantation.

    Published in:
    Frontiers in Pharmacology, 2017, p. 1, doi. 10.3389/fphar.2017.00451
    By:
    • Uppugunduri, Chakradhara Rao S.;
    • Storelli, Flavia;
    • Mlakar, Vid;
    • Huezo-Diaz Curtis, Patricia;
    • Rezgui, Aziz;
    • Théorêt, Yves;
    • Marino, Denis;
    • Doffey-Lazeyras, Fabienne;
    • Chalandon, Yves;
    • Bader, Peter;
    • Daali, Youssef;
    • Bittencourt, Henrique;
    • Krajinovic, Maja;
    • Ansari, Marc
    Publication type:
    Article
    2

    Detection of busulfan adducts on proteins.

    Published in:
    Rapid Communications in Mass Spectrometry: RCM, 2016, v. 30, n. 23, p. 2517, doi. 10.1002/rcm.7730
    By:
    • Acosta‐Martin, Adelina E.;
    • Antinori, Paola;
    • Uppugunduri, Chakradhara Rao S.;
    • Daali, Youssef;
    • Ansari, Marc;
    • Scherl, Alexander;
    • Müller, Markus;
    • Lescuyer, Pierre
    Publication type:
    Article
    3
    4

    Clinical Pharmacogenetics Implementation Consortium Guideline (CPIC) for CYP2D6, ADRB1, ADRB2, ADRA2C, GRK4, and GRK5 Genotypes and Beta‐Blocker Therapy.

    Published in:
    Clinical Pharmacology & Therapeutics, 2024, v. 116, n. 4, p. 939, doi. 10.1002/cpt.3351
    By:
    • Duarte, Julio D.;
    • Thomas, Cameron D.;
    • Lee, Craig R.;
    • Huddart, Rachel;
    • Agundez, Jose A. G.;
    • Baye, Jordan F.;
    • Gaedigk, Andrea;
    • Klein, Teri E.;
    • Lanfear, David E.;
    • Monte, Andrew A.;
    • Nagy, Mohamed;
    • Schwab, Matthias;
    • Stein, C. Michael;
    • Uppugunduri, Chakradhara Rao S.;
    • van Schaik, Ron H. N.;
    • Donnelly, Roseann S.;
    • Caudle, Kelly E.;
    • Luzum, Jasmine A.
    Publication type:
    Article
    5

    Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2C19 and Proton Pump Inhibitor Dosing.

    Published in:
    Clinical Pharmacology & Therapeutics, 2021, v. 109, n. 6, p. 1417, doi. 10.1002/cpt.2015
    By:
    • Lima, John J.;
    • Thomas, Cameron D.;
    • Barbarino, Julia;
    • Desta, Zeruesenay;
    • Van Driest, Sara L.;
    • El Rouby, Nihal;
    • Johnson, Julie A.;
    • Cavallari, Larisa H.;
    • Shakhnovich, Valentina;
    • Thacker, David L.;
    • Scott, Stuart A.;
    • Schwab, Matthias;
    • Uppugunduri, Chakradhara Rao S.;
    • Formea, Christine M.;
    • Franciosi, James P.;
    • Sangkuhl, Katrin;
    • Gaedigk, Andrea;
    • Klein, Teri E.;
    • Gammal, Roseann S.;
    • Furuta, Takahisa
    Publication type:
    Article
    6
    7
    8
    9
    10
    11
    12

    Frequency of Chemotherapy Medication Errors: A Systematic Review.

    Published in:
    Journal of Pharmacology & Pharmacotherapeutics, 2018, v. 9, n. 2, p. 86, doi. 10.4103/jpp.JPP_61_18
    By:
    • Ashokkumar, Ramkumar;
    • Srinivasamurthy, Sureshkumar;
    • Kelly, Janet J.;
    • Howard, Scott C.;
    • Parasuraman, Subramani;
    • Uppugunduri, Chakradhara Rao S.
    Publication type:
    Article
    13
    14
    15